Both in Pharmaceuticals
Q32 Bio vs Lifecore Biomedical
Over the past year QTTB returned +278.5% and LFCR returned −5.0%; their daily moves had a correlation of -0.01.
QTTB +278.5% LFCR −5.0%Growth of $1, one year, split-adjusted
| Metric | QTTB | LFCR |
|---|---|---|
| Price | $8.97 | $6.44 |
| Market cap | $267.0M | $244.1M |
| Today | +2.40% | +0.31% |
| 1 month | +10.6% | −0.2% |
| 6 months | +64.0% | +29.8% |
| Year to date | +170.2% | −21.3% |
| 1 year | +249.0% | −9.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 35.3% |
| Net margin | — | −20.9% |
| P/E (TTM) | 7.9× | — |
| Price / sales | 5.0× | — |
| Net cash | $106.3M | -$136.9M |
| Dividend yield | — | — |
| Volatility (60d) | 63.1% | 96.7% |
| Short % of float | 32.6% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).